The FITC-Dextran (60842-46-8 MW 4000) Diaries
. On the other hand, toxicity of those extremely successful PKC agonists is undoubtedly an ongoing issue, and requirement to provide the medicine by injection. At this time, synthetic analogs of bryostatin58,fifty nine and prostratin60 are now being explored, with diminished toxicity and cost of synthesis compared with their pure source counterpart